BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2812758)

  • 21. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration.
    Lefrère F; Hermine O; Audat F; Buzyn A; Cavazzana-Calvo M; Boccaccio C; Varet B
    Hematol Cell Ther; 1998 Jun; 40(3):133-7. PubMed ID: 9698222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
    Robinson S; van Os R; Sheridan T; Mauch P
    Stem Cells; 2000; 18(2):93-101. PubMed ID: 10742381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
    Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
    Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
    Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
    Wu DD; Nayar R; Keating A
    Exp Hematol; 1994 Jun; 22(6):495-500. PubMed ID: 7514543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term cryopreservation of bone marrow for autologous transplantation.
    Attarian H; Feng Z; Buckner CD; MacLeod B; Rowley SD
    Bone Marrow Transplant; 1996 Mar; 17(3):425-30. PubMed ID: 8704699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ex vivo expansion of feline marrow cells leads to increased numbers of BFU-E and CFU-GM but a loss of reconstituting ability.
    Abkowitz JL; Taboada MR; Sabo KM; Shelton GH
    Stem Cells; 1998; 16(4):288-93. PubMed ID: 9708451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
    Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culture characteristics of human granulocyte-macrophage progenitor cells and their regulation in the context of bone marrow transplantation.
    Broxmeyer HE
    Exp Hematol; 1979; 7 Suppl 5():149-58. PubMed ID: 400682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
    Tennant GB; Jacobs A; Bailey-Wood R
    Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
    Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
    Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large scale recovery and characterization of stromal cell-associated primitive haemopoietic progenitor cells from filter-retained human bone marrow.
    Blazsek I; Delmas Marsalet B; Legras S; Marion S; Machover D; Misset JL
    Bone Marrow Transplant; 1999 Apr; 23(7):647-57. PubMed ID: 10218840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
    Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
    Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.